Genpharmasec Ltd

AI
Genpharmasec Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Genpharmasec Ltd

₹ 1.07 7.00%
16 Oct - close price
genpharmasec.com BSE: 531592
About

Incorporated in 1992, Generic Pharmasec
Ltd deals in pharmaceutical activities /services and trades in equity shares[1]

Key Points

Business Overview:[1]
GPL started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and then shifted its business activities to buying, selling and distribution of pharmaceutical, medicinal and medicated preparations and also decided to deal in securities market. Currently, company is dealing in medical and diagnostics devices

Website BSE
  • Market Cap ₹ 59.2 Cr.
  • Current Price ₹ 1.07
  • High / Low ₹ 1.85 / 0.75
  • Stock P/E
  • Book Value ₹ 1.20
  • Dividend Yield 0.00 %
  • ROCE 2.68 %
  • ROE 2.36 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Stock is trading at 0.89 times its book value
  • Company is expected to give good quarter
  • Debtor days have improved from 111 to 76.3 days.
  • Company's working capital requirements have reduced from 132 days to 61.1 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 32.1%
  • Company has a low return on equity of 1.74% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.2.83 Cr.
  • Promoter holding has decreased over last 3 years: -27.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Trading & Distributors

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
6.22 7.86 6.38 10.20 5.20 6.03 8.48 14.01 12.04 32.64 39.83 55.43 49.71
6.01 7.89 6.37 10.21 5.00 5.90 7.76 15.01 11.10 33.10 41.07 53.44 48.75
Operating Profit 0.21 -0.03 0.01 -0.01 0.20 0.13 0.72 -1.00 0.94 -0.46 -1.24 1.99 0.96
OPM % 3.38% -0.38% 0.16% -0.10% 3.85% 2.16% 8.49% -7.14% 7.81% -1.41% -3.11% 3.59% 1.93%
0.06 0.15 0.14 0.31 0.57 0.75 0.81 0.94 0.69 0.46 0.98 1.02 0.37
Interest 0.06 0.07 0.00 0.16 0.10 0.07 0.16 0.11 0.12 0.23 0.41 0.48 0.40
Depreciation 0.01 0.00 0.12 0.03 0.16 0.30 0.10 0.26 0.27 0.56 0.67 0.68 0.67
Profit before tax 0.20 0.05 0.03 0.11 0.51 0.51 1.27 -0.43 1.24 -0.79 -1.34 1.85 0.26
Tax % -420.00% 80.00% -100.00% 345.45% 35.29% -39.22% 40.16% -37.21% 2.42% 48.10% -37.31% 27.03% 165.38%
1.05 0.01 0.06 -0.27 0.33 0.70 0.76 -0.27 1.22 -1.18 -0.83 1.36 -0.17
EPS in Rs 0.02 0.00 0.00 -0.00 0.01 0.01 0.01 -0.00 0.02 -0.02 -0.01 0.03 0.00
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
26 30 34 140 178
25 30 33 139 176
Operating Profit 0 0 0 1 1
OPM % 1.0% 0.1% 1.2% 0.9% 0.7%
0 1 3 3 3
Interest 0 0 0 1 2
Depreciation 0 0 1 2 3
Profit before tax 0 0 2 1 -0
Tax % -300% 168% 29% 42%
1 -0 2 1 -1
EPS in Rs 0.02 -0.00 0.03 0.03 -0.00
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 76%
TTM: 338%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 11%
TTM: -111%
Stock Price CAGR
10 Years: 20%
5 Years: -25%
3 Years: -24%
1 Year: -40%
Return on Equity
10 Years: %
5 Years: %
3 Years: 2%
Last Year: 2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 28 55 55 55
Reserves -12 9 10 11
3 4 5 35
1 3 9 37
Total Liabilities 20 71 80 138
0 1 8 41
CWIP 0 0 0 0
Investments 1 19 20 2
19 51 53 95
Total Assets 20 71 80 138

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
-3 -3 3 -18
0 -28 -4 13
3 48 -1 4
Net Cash Flow 0 17 -3 -0
Free Cash Flow -3 -3 -3 -18
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -1,277% -7,275% 774% -1,274%

Ratios

Consolidated / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 82 109 147 76
Inventory Days 151 133 89 40
Days Payable 21 36 101 91
Cash Conversion Cycle 211 207 135 26
Working Capital Days 199 213 123 61
ROCE % 2% 4% 3%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of Permanent Employees
employees ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Diagnostic Pharma Equipment Segment Revenue (Standalone)
Rs. in Lakhs ・Standalone data
Trading in Securities Segment Revenue (Standalone)
Rs. in Lakhs ・Standalone data
i-STAT Analyzers Imported (units)
units ・Standalone data
Simulators Imported (units)
units ・Standalone data
i-STAT Cartridges Imported (units)
units ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

4 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
59.96% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 29.98% 32.06%
40.04% 70.02% 70.02% 70.02% 70.02% 70.02% 70.02% 70.03% 70.01% 70.02% 70.02% 67.95%
No. of Shareholders 89,4381,08,1371,08,2201,05,8381,09,2061,09,0801,07,6021,05,8041,04,0211,02,2521,01,13499,856

Documents

Announcements

Annual reports